Insider Selling: Heartflow (NASDAQ:HTFL) CFO Sells 668 Shares of Stock

September 16, 2026 by InsiderTrades.com

Key Points

CFO Vikram Verghese sold 29,714 Heartflow shares for approximately $1.49 million at an average price of $50.06, reducing his position by 13.85%. The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, and he retained 184,789 shares.
Heartflow reported strong operating momentum in its latest quarter, with revenue rising 47.7% year over year to $64.08 million and a loss of $0.07 per share that was narrower than analysts expected.
Analysts remain broadly positive, with a consensus “Moderate Buy” rating and an average price target of $44.88, while the stock recently traded near its 52-week high despite ongoing insider selling.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CFO Vikram Verghese sold 668 shares of the business's stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $50.01, for a total value of $33,406.68. Following the completion of the sale, the chief financial officer owned 179,528 shares of the company's stock, valued at approximately $8,978,195.28. This trade represents a 0.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total value of $230,752.32.
On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The shares were sold at an average price of $50.06, for a total value of $1,487,482.84.
On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The shares were sold at an average price of $50.03, for a total value of $332,199.20.
On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total value of $1,368,462.60.
On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total value of $297,325.60.

Heartflow Stock Down 2.4%

HTFL stock opened at $48.33 on Wednesday. Heartflow, Inc. has a 52 week low of $20.13 and a 52 week high of $51.78. The business has a 50-day simple moving average of $36.39 and a 200 day simple moving average of $31.21. The company has a market cap of $4.20 billion and a PE ratio of -26.41.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.22) by $0.15. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The firm had revenue of $64.08 million for the quarter. The company's revenue for the quarter was up 47.7% compared to the same quarter last year. On average, analysts anticipate that Heartflow, Inc. will post -0.75 EPS for the current fiscal year.

Key Heartflow News

Here are the key news stories impacting Heartflow this week:

Positive Sentiment: Heartflow’s latest quarterly results showed strong operating momentum: revenue rose 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than analysts expected. Heartflow stock and earnings information
Positive Sentiment: Several institutions recently initiated or increased positions, including Squarepoint Ops, which lifted its stake by 72%, providing a potential source of buying support.
Positive Sentiment: Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating. UBS set a $55 price target, above the recent trading range, while other firms maintained Buy or Overweight ratings.
Neutral Sentiment: The CFO’s sales were disclosed as part of a planned trading program, reducing the likelihood that the transactions represent a new negative view of Heartflow’s business. After selling 35,?—actually 35,? shares across September 11–15, CFO Vikram Verghese still owned roughly 179,528 shares.
Negative Sentiment: CFO Vikram Verghese sold a combined 34,975 shares for approximately $1.75 million at prices near $50 per share, reducing his direct ownership by roughly 16.7% over the reported transactions. CFO SEC filing
Negative Sentiment: CEO John Farquhar also sold 38,900 shares for approximately $1.82 million on September 10–11 and has reported multiple sales since June. The repeated selling by senior executives, particularly after the stock approached its 52-week high, is likely contributing to short-term pressure. HeartFlow CEO share sale

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on HTFL. Morgan Stanley lifted their price objective on shares of Heartflow from $35.00 to $40.00 and gave the company an "equal weight" rating in a research note on Friday, August 14th. Wells Fargo & Company raised their target price on Heartflow from $37.00 to $39.00 and gave the company an "overweight" rating in a report on Friday, August 14th. Robert W. Baird set a $45.00 price target on Heartflow in a research note on Friday, August 14th. UBS Group started coverage on Heartflow in a report on Wednesday, September 9th. They set a "neutral" rating and a $55.00 price target for the company. Finally, Weiss Ratings upgraded Heartflow from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Heartflow currently has an average rating of "Moderate Buy" and an average price target of $44.88.

View Our Latest Research Report on HTFL

Hedge Funds Weigh In On Heartflow

A number of institutional investors have recently added to or reduced their stakes in HTFL. XXEC Inc. bought a new stake in shares of Heartflow during the second quarter worth $2,524,764,000. BlackRock Inc. bought a new position in shares of Heartflow in the 2nd quarter valued at $152,502,000. Bamco Inc. NY bought a new position in shares of Heartflow in the 2nd quarter valued at $94,625,000. Jupiter Topco LLC acquired a new stake in shares of Heartflow during the 2nd quarter valued at $70,983,000. Finally, Janus Henderson Group PLC grew its position in Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company's stock worth $53,063,000 after acquiring an additional 1,315,416 shares during the last quarter.

About Heartflow

(Get Free Report)

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries.

The company's primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).